What are the treatment options for Postural Orthostatic Tachycardia Syndrome (POTS)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 2, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Treatment for Postural Orthostatic Tachycardia Syndrome (POTS) should prioritize a combination of lifestyle modifications, including salt and fluid loading, elevation of the head of the bed, and use of support stockings, alongside a formalized exercise program, as these interventions address the reduction in plasma volume and support long-term cardiovascular health 1.

Lifestyle Modifications

Key lifestyle modifications for POTS include:

  • Salt loading through liberalized sodium intake (5-10 g or 1-2 teaspoons of table salt per day) to expand blood volume
  • Drinking 3 liters of water or an electrolyte-balanced fluid per day
  • Elevation of the head of the bed with 4–6-inch (10–15-cm) blocks during sleep
  • Use of waist-high support stockings to ensure sufficient support of central blood volume
  • Avoiding factors that contribute to dehydration, such as alcohol, caffeine, large heavy meals, and excessive heat exposure

Exercise Program

A formalized exercise program is crucial for patients with POTS, which may be best initiated in a supervised setting with a physical therapist or through specific instructions for implementation at home or in a gym 1. The program should support long-term cardiovascular health and may involve recumbent exercises initially, progressing to upright activities.

Pharmacological Interventions

While no pharmacological therapies are currently approved for POTS, various treatments may be used empirically, including:

  • Low-dose beta-blockers (e.g., bisoprolol, metoprolol, nebivolol, propranolol) or nondihydropyridine calcium-channel blockers (e.g., diltiazem, verapamil) to slow the heart rate
  • Ivabradine for severe fatigue exacerbated by beta-blockers and calcium-channel blockers
  • Fludrocortisone (up to 0.2 mg taken at night) in conjunction with salt loading to increase blood volume
  • Midodrine (2.5-10 mg) to help with orthostatic intolerance, with careful dosing to avoid excessive effects

Individualized Treatment

Treatment for POTS should be individualized, considering the variability in severity and symptom presentation among patients 1. The goal is to improve orthostatic tolerance by addressing the underlying autonomic dysfunction and cardiovascular deconditioning, thereby enhancing quality of life and reducing morbidity and mortality.

From the Research

Treatment Options for Postural Orthostatic Tachycardia Syndrome (POTS)

  • Intravenous saline infusions: Studies have shown that intermittent intravenous saline infusions can dramatically reduce symptoms and improve quality of life in patients with POTS 2.
  • Salt supplementation: Salt supplementation has been found to improve susceptibility to vasovagal syncope and associated symptoms in patients with POTS, with little effect on supine blood pressure 3.
  • Medications:
    • Propranolol, bisoprolol, and pyridostigmine have been shown to be effective in improving orthostatic intolerance symptoms, depression, and quality of life in patients with POTS 4.
    • Bisoprolol and fludrocortisone have been found to improve symptoms and autonomic-hemodynamic disturbances in patients with POTS 5.
    • Ivabradine, a selective inhibitor of funny sodium channels, has been shown to improve symptoms of POTS, although further research is needed to confirm its effectiveness 6.

Key Considerations

  • Treatment should be individualized based on the patient's specific symptoms and needs.
  • Patients with POTS may require a combination of treatments to manage their symptoms effectively.
  • Further research is needed to fully understand the pathophysiology of POTS and to develop effective treatment strategies.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Effects of intermittent intravenous saline infusions in patients with medication-refractory postural tachycardia syndrome.

Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing, 2017

Research

Efficacy of Propranolol, Bisoprolol, and Pyridostigmine for Postural Tachycardia Syndrome: a Randomized Clinical Trial.

Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics, 2018

Research

Clinical improvement in patients with orthostatic intolerance after treatment with bisoprolol and fludrocortisone.

Clinical autonomic research : official journal of the Clinical Autonomic Research Society, 2000

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.